Considerations for extrapolating evidence of acute and chronic pain analgesic efficacy

Robert H Dworkin1, Dennis C Turk, Ethan Basch

  • 1Departments of Anesthesiology and Neurology, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA, USA Memorial Sloan-Kettering Cancer Center, New York, NY, USA National Institutes of Health Clinical Center, Bethesda, MD, USA M.D. Anderson Cancer Center, Houston, TX, USA Department of Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, USA Department of Psychiatry & Behavioral Sciences, Johns Hopkins University, Baltimore, MD, USA Department of Rehabilitation Medicine, University of Washington, Seattle, WA, USA Pain Research Informatics, Medical Comorbidities and Education Center, VA Connecticut Healthcare System and Departments of Psychiatry, Neurology and Psychology, Yale University, New Haven, CT, USA Department of Neurosurgery, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA National Institutes of Health, Bethesda, MD, USA Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University, Baltimore, MD, USA Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, NY, USA Department of Anesthesiology, University of California San Diego, San Diego, CA, USA Children's Hospital and Harvard Medical School, Boston, MA, USA.

Pain
|March 15, 2011
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each indication due to...